Clinical Trial Detail

NCT ID NCT03844815
Title Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Chicago
Indications

acute myeloid leukemia

Therapies

Decitabine + Venetoclax

Age Groups: adult senior

No variant requirements are available.